We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Chicken Antibodies Guide Cancer-Killing Nanotubes

By LabMedica International staff writers
Posted on 18 Dec 2009
A recent paper described a novel hi-tech mechanism for tracking and destroying cancer cells. More...
The method is based on a highly specific chicken antibody (immunoglobulin Y, or IgY) directed at the cancer cell surface HER2 (human epidermal growth factor receptor 2) protein covalently bound to single-walled nanotubes.

The nanotubes (SWNTs) exhibit two unique optical properties that make them useful for this application. When exposed to laser light at a wavelength of 785 nanometers, a strong Raman signal is given off that can be detected with a special Raman microscope. Exposure to laser light at 808 nanometers (near infrared or NIR) causes the SWNTs to heat up, which results in thermal destruction of living tissue in the near vicinity.

Investigators at the [U.S.] National Institute of Standards and Technology (Gaithersburg, MD, USA) worked with two types of cancer cells growing in tissue culture. Both HER2-expressing SK-BR-3 cells and HER2-negative MCF-7 cells were treated with the IgY-SWNTs and then exposed to different wavelengths of laser light.

Results published in the October 2, 2009, issue of the journal BMC Cancer revealed that the anti-HER2 IgY guided the nanotubes to those cells expressing HER2. Thus, the Raman signal collected at single-cell level from the SWNT-treated SK-BR-3 cells was significantly greater than that from the MCF-7 cells. Exposure to NIR irradiation selectively destroyed the SWNT-targeted breast cancer cells without harming receptor-free cells. Significantly, cell death was effectuated without the need of internalization of SWNTs by the cancer cells.

The authors concluded that, "The complex can be potentially used for both detection and selective photothermal ablation of receptor-positive breast cancer cells without the need of internalization by the cells. Thus, the unique intrinsic properties of SWNTs combined with high specificity and sensitivity of IgY antibodies can lead to new strategies for cancer detection and therapy."

Related Links:
[U.S.] National Institute of Standards and Technology


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Collection and Transport System
PurSafe Plus®
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel

Groundbreaking Tool Improves Genetic Testing Accuracy

Genetic testing plays a crucial role in diagnosing disease, but its accuracy depends heavily on understanding how common certain genetic variants are across populations. Most current databases calculate these frequencies using averages across broad groups, which can obscure important ancestry-specific differences.... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.